Compare BMY & BE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMY | BE |
|---|---|---|
| Founded | 1887 | 2001 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.3B | 86.0B |
| IPO Year | N/A | 2018 |
| Metric | BMY | BE |
|---|---|---|
| Price | $56.29 | $257.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | $61.73 | ★ $177.67 |
| AVG Volume (30 Days) | ★ 9.4M | 8.1M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $2,023,994,000.00 |
| Revenue This Year | N/A | $64.67 |
| Revenue Next Year | N/A | $60.22 |
| P/E Ratio | ★ $17.26 | $1,103.89 |
| Revenue Growth | N/A | ★ 37.33 |
| 52 Week Low | $42.52 | $20.93 |
| 52 Week High | $62.89 | $322.83 |
| Indicator | BMY | BE |
|---|---|---|
| Relative Strength Index (RSI) | 46.46 | 45.61 |
| Support Level | $53.50 | $245.43 |
| Resistance Level | $57.04 | $312.91 |
| Average True Range (ATR) | 1.42 | 22.95 |
| MACD | -0.06 | -7.39 |
| Stochastic Oscillator | 33.88 | 18.87 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. Bloom sells its systems in the United States and internationally.